Boehringer Ingelheim Investigational Site

Toronto, Ontario M4R 2G4

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, Diabetic Nephropathies, HIV Infections, Hypertension, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) — Completed
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN — Completed
• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin — Completed
• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC — Completed
• Tiotropium / Respimat One-Year Study — Completed
• Tiotropium / Respimat One-Year Study — Completed
• SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed
• 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD — Completed
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed